Working toward medicines made in Angola.
Milongo is building on the published research of an Angolan scientist to help Angola produce the essential medicines it now imports.
See the researchOur name
A word for medicine that Angola already knows.
Milongo means medicine in Kimbundu, one of Angola's national languages. We chose it because our purpose is simple: medicine for Angolans, made by Angolans, in Angola.
The research
Peer-reviewed work, led by an Angolan engineer.
Many antibiotics are made by fermentation, usually in submerged liquid culture. Dr. Teresa Matoso Victor's research grows the antibiotic-producing microorganism on a solid, porous matrix instead. This is solid-state fermentation. In the laboratory, that method produced more antibiotic than the conventional liquid method. The reactor provides the controlled conditions for the microorganism to grow and produce the antibiotic with maximum yield.
More from the same organism
Two well-studied research antibiotics were produced at 2 to 5 times and 6 to 17 times the level of conventional liquid culture.
Read the paperWhy it works
A comparison of proteins found an enzyme linked to higher antibiotic production in the cultures grown on the matrix.
Read the paperA purpose-built reactor
The method was run in a 16-bed laboratory reactor designed for the work, and the extracts were shown to inhibit test microbes.
Read the paperThis research is still at the laboratory stage. Our next step is to show that the same approach works for the medicines Angola relies on.
Leadership
The leaders driving Milongo forward.
Dr. Teresa Matoso M. Victor
Chief Scientist
Dr. Victor is an Angolan chemical engineer with a PhD in Chemical Engineering and a Master's in Sustainable Chemical Engineering from the University of Newcastle upon Tyne in the United Kingdom. Her research spans process intensification, polymerisation and catalysis, materials science and renewable energy. She is an associate professor, on secondment, at the Higher Polytechnic Institute of Technologies and Sciences (ISPTEC) in Luanda. She received the International Best Researcher Award in Chemical Engineering and Biotechnology (IISTAC-2022) and the MESCTI Fair prize for innovation in Luanda. At Milongo she leads the research and scientific direction.
Paul Kamps
Chief Executive Officer
Paul brings four decades of finance and operating experience. He began his career in public accounting, including at Ernst & Young, then held senior finance roles at private equity-backed companies in technology, healthcare and consulting. He has owned and operated five businesses and guided one through an exit into a private equity roll-up. Paul is South African and leads Milongo's finance, governance and corporate strategy. Away from work, he is usually on the golf course or sailing.
Hilton Kamps
Head of Business Development
Hilton leads partnerships and business development, working with governments, research institutions and industry partners to move Milongo's work forward. An American, he has built his career in technology and has founded three companies. He is driven by a strong interest in technology and in applying it to help other people. He studied Business Management, with a concentration in Supply Chain & Operations, and Economics at Rollins College, where he sailed competitively.
Contact
Talk to us.
We welcome conversations with health authorities, research institutions and partners. info@milongopharma.com